Mesoblast announced a new five-year facility to draw down up to US$125 million by June 30, 2026. This facility was provided by existing shareholder Dr. Gregory George and has a fixed interest rate of 8.00% per annum. The initial US$75 million drawn is unsecured until the remainder of the NovaQuest debt is repaid. The new facility has a lower overall cost, no early prepayment fees, and does not encumber any of Mesoblast’s assets or intellectual property. Mesoblast’s CEO expressed gratitude for the support and flexibility this new facility provides for strategic partnerships and commercialization efforts.

Read more at GlobeNewswire: Mesoblast Retires Senior Debt with Non-Dilutive, Lower